Trademark: 90553103
Word
REVATIS REGENERATIVE MEDICINE AND CELL THERAPY
Status Date
Tuesday, May 31, 2022
Registration Number
6742715
Registration Date
Tuesday, May 31, 2022
Filing Date
Monday, March 1, 2021
Published for Opposition
Tuesday, March 15, 2022
40 Cell cryopreservation services
5 Pharmaceutical products for regenerative medicine; orthopedic articles, namely, lubricating gel
44 Veterinary services; Beauty and hygiene care services for animals; Skin care services being hygiene and beauty care; medical services
10 Medical apparatus and instruments for veterinary purposes and for use in surgery as it relates to regenerative medicine; cell culture apparatus for medical or veterinary use, namely, cell culture chambers; orthopedic articles, namely, bone prostheses, joint prostheses, medical instruments for use in performing biopsies in the nature of microbiopsies
42 Development of pharmaceutical products; development of cell therapy products; development of technologies for the manufacture and processing of cells for use in advanced cell therapy; Research and development of new products for others
The mark consists of a blue rectangular carrier in which appears the stylized wording "REVATIS" where "REVA" appears in green and "TIS" appears in white with the letter "I" formed by three vertically aligned white dots; below this wording appears the smaller stylized white wording "REGENERATIVE MEDICINE AND CELL THERAPY".
The color(s) blue, green and white is/are claimed as a feature of the mark.
"REGENERATIVE MEDICINE AND CELL THERAPY"
May 31, 2022
Notice Of Registration Confirmation Emailed
May 31, 2022
Registered-Principal Register
Mar 15, 2022
Official Gazette Publication Confirmation E-Mailed
Mar 15, 2022
Published For Opposition
Feb 23, 2022
Notification Of Notice Of Publication E-Mailed
Feb 10, 2022
Law Office Publication Review Completed
Feb 8, 2022
Approved For Pub - Principal Register
Feb 8, 2022
Examiner's Amendment Entered
Feb 8, 2022
Notification Of Examiners Amendment E-Mailed
Feb 8, 2022
Examiners Amendment E-Mailed
Feb 8, 2022
Examiners Amendment -Written
Feb 8, 2022
Teas/Email Correspondence Entered
Feb 8, 2022
Correspondence Received In Law Office
Feb 1, 2022
Assigned To Lie
Jan 28, 2022
Teas Response To Office Action Received
Sep 22, 2021
Notification Of Non-Final Action E-Mailed
Sep 22, 2021
Non-Final Action E-Mailed
Sep 22, 2021
Non-Final Action Written
Sep 22, 2021
Assigned To Examiner
Jun 1, 2021
Notice Of Design Search Code E-Mailed
May 30, 2021
New Application Office Supplied Data Entered In Tram
Mar 4, 2021
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
